Related Experiment Videos

NK1 receptor fused to beta-arrestin displays a single-component, high-affinity molecular phenotype

Lene Martini1, Hanne Hastrup, Birgitte Holst

  • 1Laboratory for Molecular Pharmacology, Department of Pharmacology, The Panum Institute, University of Copenhagen, Denmark.

Insights

Fusion of beta-arrestin1 to the neurokinin NK1 receptor created a stable complex. This NK1-beta-arrestin1 fusion protein exhibits ideal binding properties, making it suitable for structural analysis.

Area of Science:

  • Molecular pharmacology
  • Cell biology
  • Structural biology

Background:

  • Arrestins are key regulators of seven transmembrane (7TM) receptor signaling, terminating downstream pathways.
  • Neurokinin NK1 receptor (NK1R) mediates signaling via G proteins and is regulated by arrestins.
  • Understanding receptor-arrestin interactions is crucial for drug development and signaling pathway elucidation.

Purpose of the Study:

  • To investigate the functional and binding properties of a chimeric NK1 receptor fused to beta-arrestin1.
  • To determine if constitutive arrestin binding alters NK1 receptor ligand affinity and signaling.
  • To assess the potential of the NK1-beta-arrestin1 fusion for structural studies.

Main Methods:

  • Construction and expression of a chimeric NK1 receptor fused to beta-arrestin1.
  • Cell surface expression analysis and localization studies using transferrin.
  • Agonist and antagonist binding assays to determine ligand affinities and kinetics.
  • Functional signaling assays to assess G protein-mediated pathways (Gq/G11 and Gs).

Main Results:

  • The NK1-beta-arrestin1 fusion protein was expressed on the cell surface and in recycling endosomes.
  • The fusion protein was functionally silenced for G protein-mediated signaling.
  • Unlike wild-type NK1R, the fusion protein exhibited similar high affinities for agonists (substance P, neurokinin A) and antagonists, with Hill coefficients near unity.
  • This indicates a stable, high-affinity agonist-binding conformation upon arrestin complexation.

Conclusions:

  • Constitutive fusion of beta-arrestin1 to the NK1 receptor stabilizes an agonist-bound conformation.
  • The NK1-beta-arrestin1 complex displays near-ideal binding properties, simplifying ligand affinity determination.
  • This stabilized receptor-arrestin complex is a promising candidate for high-resolution structural analysis.

Related Concept Videos